Comparison of 2 Different Resin Based Filling Materials in Posterior Teeth - a Multicenter Study
Clinical Investigation of a New Nanohybrid Resin Composite Venus Pearl in Class 2 Cavities- a Multi-center Study
1 other identifier
interventional
130
2 countries
2
Brief Summary
The purpose of this study is to compare the clinical performance of a new resin based filling material to an established resin-based filling material in posterior teeth at 2 different study centers.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2013
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 15, 2013
CompletedFirst Posted
Study publicly available on registry
August 19, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2022
CompletedResults Posted
Study results publicly available
October 28, 2024
CompletedOctober 28, 2024
October 1, 2024
9.1 years
August 15, 2013
March 15, 2024
October 25, 2024
Conditions
Outcome Measures
Primary Outcomes (15)
Score for Surface Luster
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of esthetic properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for surface luster
2 years
Score for Surface Staining
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of esthetic properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for surface staining
2 years
Score for Marginal Discoloration
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of esthetic properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for marginal discoloration
2 years
Score for Fracture and Retention
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of functional properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for fracture and retention
2 years
Score for Color Match
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of esthetic properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for color match
2 years
Score for Esthetic Anatomical Form
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of esthetic properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for esthetic anatomical form
2 years
Score for Marginal Adaptation
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of functional properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for marginal adaptation
2 years
Score for Abrasion
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of functional properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for abrasion
2 years
Score for Approximal Anatomical Form
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of functional properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for approximal anatomical form
2 years
Score for Satisfaction of Patient
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of functional properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for satisfaction of patient
2 years
Score for Post-operative Hypersensitivity
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of biological properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for post-operative hypersensitivity
2 years
Score for Caries, Erosion
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of biological properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for caries, erosion
2 years
Score for "Tooth Integrity"
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of biological properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for "tooth integrity"
2 years
Score for Parodontal Reaction
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of biological properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for parodontal reaction
2 years
Score for Adjacent Mucosa
The primary endpoint will be a mean score calculated as following: There are three aspects to be assessed: aesthetic, functional attribute and biological parameters. Score of biological properties: 1: Clinically excellent, 2: Clinically good, 3: Clinically sufficient, 4: Clinically unsatisfactory, 5: Clinically poor Score for adjacent mucosa
2 years
Study Arms (2)
Venus Pearl
EXPERIMENTALPlacement of restoration using Venus Pearl in carious teeth or as a replacement of a defective previous restoration.
control resin-based filling material
ACTIVE COMPARATORPlacement of restoration using a control resin-based filling material in carious teeth or as a replacement of a defective previous restoration.
Interventions
Placement of restorations
Eligibility Criteria
You may qualify if:
- Patients should be 18 years and older.
- Study teeth should have an interproximal (Class II) carious lesion or an existing defective class II restoration requiring restorative therapy on premolars or molars.
- The maximum cavity depth determined by the radiograph will be D2 (Tyas classification).
- The teeth included in the study need to have a proximal contact with the adjacent tooth and be in occlusion with the opposing dentition.
- The teeth included in the study should be vital with no signs of pulpal pathology.
- Patients that report brushing regularly without severe gingival inflammation and/or extensive caries.
- Patients should have no allergies or systemic diseases which inhibit the treatment.
- Patients should have voluntary participation and sign a written informed consent form.
- Patients should be willing to participate in the recall/re-examination appointments.
You may not qualify if:
- Simultaneous participation in another study about dental restorative materials.
- Written informed consent form not signed.
- Nonvital pulp / periapical lesion.
- Insufficient oral hygiene despite detailed instructions.
- Pregnancy/ breast feeding before placement of the study restoration.
- Minors.
- Severe malocclusion/ malalignment/ traumatic occlusion/ bruxism.
- Known allergy to any components present in any of the materials that are used for this study.
- Unclear mucosal alterations, e.g. oral lichenoid reactions/lesions.
- Severe medical complications (organ transplants, cancer, immune-compromised, long-term antibiotic or steroid therapy).
- Infectious diseases such as HIV/Aids, Hepatitis, etc.
- Application of bleaching products less than 14 days before placement of the restoration.
- Orthodontic treatment during the study.
- Xerostomia.
- Untreated periodontal diseases.
- +6 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Oregon Health and Science University-School of Dentistry
Portland, Oregon, 97239, United States
Medical School Hannover
Hanover, 30625, Germany
Results Point of Contact
- Title
- Global Scientific Affairs Management
- Organization
- Kulzer GmbH
Study Officials
- STUDY CHAIR
Werner Geurtsen, Prof. Dr.
Hannover Medical School
- PRINCIPAL INVESTIGATOR
Gabriela Ibarra, DDS, MPH, MS
Oregon Health and Science University
- PRINCIPAL INVESTIGATOR
Werner Geurtsen, Prof. Dr.
Medical School Hannover
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- GT60
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 15, 2013
First Posted
August 19, 2013
Study Start
June 1, 2013
Primary Completion
July 1, 2022
Study Completion
July 1, 2022
Last Updated
October 28, 2024
Results First Posted
October 28, 2024
Record last verified: 2024-10